Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07800845Phase 4Not yet recruiting
A Phase 4 trial of remifentanil in emergence delirium (ED), sponsored by Konya City Hospital. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07800845.